Databoost Sdn Bhd

Databoost Sdn Bhd is a Malaysian technology company that develops artificial intelligence software for medical imaging. It is the developer of Fractify, a clinical AI diagnostic engine marketed to hospitals and diagnostic centres. According to its official product site, Fractify analyses X-ray, CT, MRI and dental X-ray images using deep learning and produces structured diagnostic reports that include confidence scores, five-level urgency scoring, Grad-CAM heatmaps and critical alerts for life-threatening conditions. The platform is positioned as a Clinical Decision Support System (CDSS) that augments rather than replaces doctors and radiologists, with all findings requiring physician review and sign-off. The company's flagship product, Fractify, is presented as a single AI diagnostic engine covering multiple imaging modalities — X-ray, CT, MRI and dental imaging — so that read quality remains consistent regardless of shift, volume or location. Its published performance figures include 97.9% accuracy in brain MRI tumour detection and 97.7% accuracy in bone fracture detection, with support for 18+ chest X-ray pathologies, six brain CT haemorrhage subtypes and five-level urgency scoring with critical flags. Reports are described as schema-based structured outputs covering condition, severity, confidence, differentials and follow-up, designed to be consistent, auditable and EHR-ready. Databoost Sdn Bhd is headquartered in Malaysia and its Fractify platform is described as deployed in hospitals and diagnostic centres across Asia and the Middle East. The company operates in the health-technology and enterprise software space, combining medical imaging AI with clinical workflow integration. Its public-facing materials emphasise a privacy-first approach, stating that no protected health information (PHI) is held on the marketing site. As a private Malaysian company, Databoost Sdn Bhd is not publicly listed and detailed corporate information such as founding year, founders, ownership structure and executive leadership is not established in the available evidence. The brand is best understood through its product Fractify, which represents its commercial entry into the clinical AI imaging market.

Databoost Sdn Bhd is a Malaysian technology company that develops artificial intelligence software for medical imaging. It is the developer of Fractify, a clinical AI diagnostic engine for hospitals and diagnostic centres. The company is headquartered in Malaysia and its platform is described as deployed across Asia and the Middle East. Fractify is presented as a single AI diagnostic engine that analyses X-ray, CT, MRI and dental X-ray images using deep learning. It delivers structured diagnostic reports with confidence scores, five-level urgency scoring, Grad-CAM heatmaps and critical alerts for seven life-threatening conditions. Published performance figures include 97.9% accuracy in brain MRI tumour detection and 97.7% accuracy in bone fracture detection, with support for 18+ chest X-ray pathologies and six brain CT haemorrhage subtypes. The platform is positioned as a Clinical Decision Support System (CDSS) that augments doctors and radiologists rather than replacing them; all findings require physician review and sign-off. Reports are schema-based structured outputs covering condition, severity, confidence, differentials and follow-up, designed to be consistent, auditable and EHR-ready. The company emphasises a privacy-first approach, stating that no protected health information (PHI) is held on its marketing site. Detailed corporate history — including founding year, founders, ownership and executive leadership — is not established in the available evidence. The brand is best understood through its product Fractify and its commercial focus on clinical AI imaging for hospitals and diagnostic centres in Asia and the Middle East.

Clinical Decision Support System (CDSS) that augments doctors and radiologists with AI-driven imaging analysis; privacy-first, multi-modality, structured and auditable reporting.

• Fractify

  Clinical AI diagnostic engine for medical imaging developed by Databoost Sdn Bhd. Analyses X-ray, CT, MRI and dental X-ray images using deep learning; delivers structured diagnostic reports with confidence scores, five-level urgency scoring, Grad-CAM heatmaps and critical alerts for seven life-threatening conditions. Achieves 97.9% accuracy in brain MRI tumour detection and 97.7% accuracy in bone fracture detection; supports 18+ chest X-ray pathologies and six brain CT haemorrhage subtypes. Positioned as a Clinical Decision Support System (CDSS) requiring physician review and sign-off.

1. 1Fractify | AI Radiology Engine for Hospitals — 97.9% Accuracy, DICOM, Urgency Scoringaiscan.fractify.net
2. 2Databoost Sdn Bhdwikidata.org